[1]
M. Bragagni, N. Mennini, C. Ghelardini, and P. Mura, “Development and Characterization of Niosomal Formulations of Doxorubicin Aimed at Brain Targeting”, J Pharm Pharm Sci, vol. 15, no. 1, pp. 184–196, Feb. 2012.